TuHURA Biosciences HURA
NASDAQ HURA
$2.08 -0.01 (-0.24%)
As of: Oct 22, 2026 · 10:26 AM EDT

TuHURA Biosciences (HURA) Restructuring Costs (2025)

Updated

TuHURA Biosciences' Restructuring Costs came in at $419,042 for FY2025, down 4.8% from $440,340 in FY2024.

Analysis

TuHURA Biosciences (HURA) Restructuring Costs (2025) Analysis & Trends

  • Per Business Quant, earlier years put Restructuring Costs at $440,340 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.70 Bn 1,135.28 Bn 19.71 Bn
2 Johnson & Johnson 633.99 Bn 552.52 Bn 17.26 Bn
3 AbbVie 502.96 Bn 476.07 Bn 12.70 Bn
4 Merck 377.09 Bn 331.47 Bn 12.21 Bn
5 Novartis Ag 303.78 Bn 267.77 Bn 11.24 Bn
6 Astrazeneca 266.66 Bn 240.35 Bn 12.86 Bn
7 Amgen 241.39 Bn 196.79 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn
10 TuHURA Biosciences 132.20 Mn 118.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 3.09 Mn
Mar 31, 2025 419,042.00
API Access

TuHURA Biosciences Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=HURA&period=max&api_key=YOUR_API_KEY